Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Israel / NCT07594613
Starting soon Observational

Family Patterns in Resting Metabolic Rate Between Parents and Adult Children

NCT07594613 · tracked via the Priya Life Science Israel tracker
Sponsor
Tel Aviv University
Phase
Observational
Started
2026-06
Last updated
2026-05-19

Condition(s) studied

Resting Metabolic RateMetabolism Disorders

Study summary

This study examines whether resting metabolic rate (RMR)-the amount of energy the body uses at rest-is similar between biological parents and their adult children (aged 18 years and older). RMR is the largest component of daily energy expenditure and plays an important role in body weight regulation and overall metabolic health.

Participants from the same family will undergo a single testing session in a metabolic laboratory. RMR will be measured using indirect calorimetry under standardized conditions, along with body composition assessment and basic health information.

The primary goal is to determine whether RMR is correlated within families. The study will also assess whether these similarities remain after accounting for differences in body composition, age, and sex.

This observational study will help improve understanding of how metabolism varies between individuals and the extent to which these differences may be influenced by familial or inherited factors. Findings may contribute to future research on personalized nutrition, obesity risk, and metabolic health.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Biological parent-adult child pairs * Adult children aged ≥18 years * Parents aged 40-60 years * Ability to comply with study procedures, including fasting and resting conditions * Generally healthy individuals without acute illness Exclusion Criteria: * Current weight loss or active dieting * Known metabolic disorders (e.g., thyroid disease) * Use of medications affecting metabolic rate * Pregnancy * Acute illness at the time of testing * Inability to comply with pre-test requirements (e.g., fasting, avoiding exercise or caffeine)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sylvan Adams Sport Science Institute Tel Aviv Israel

More Tel Aviv University trials in Israel

AI-Guided Sarcopenia Risk Assessment and Detection Active, not recruiting
Efficacy of Attention Bias Modification vs. Placebo for Social Anxiety Disorder Recruiting
Cognitive-behavioral Therapy for Insomnia in School-aged Children Recruiting
Emotion Regulation Selection Flexibility Training for PTSD Patients Recruiting
Mapping Metabolic Organ Plasticity in Energy Adaptation Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07594613 on ClinicalTrials.gov ↗ ← All trials in Israel